Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal Impact Factor 0.532*
Submit manuscript at https://www.editorialmanager.com/biomedicaljournals/ or send as an e-mail attachment to the Editorial Office at [email protected]
Journal of Hematology & Thromboembolic Diseases is a peer reviewed medical journal that includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal. The editorial office promises a thorough peer review of the submitted manuscripts to ensure quality.
|This is one of the best open access journals that aims to publish the most complete and reliable source of information on discoveries and current developments as original articles, review articles, case reports, short communications, etc. in the field and provides online access without any restrictions or subscriptions to researchers worldwide.|
|Journal of Hematology and Thromboembolic Diseases is a peer reviewed journal, serving the International Scientific Community. This Hematology journal offers an open access platform to the authors to publish their research outcome.|
OMICS International organizes 1000+ conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ scholarly open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.“Hematology and Thromboembolic Diseases” is an open access Journal dedicated to publish high quality research in this field. The Journal is a vast repository of Hematological research with a very broad scope. In addition to featuring traditional hematology topics such as Thalassemia, Sickle Cell Disease, HemolyticAnemia, Rh incompatibility, Myelodysplastic Syndrome, Aplastic Anemia, Spherocytosis, Donor blood/Allo-immunization, embolism, and Von Willebrand's disease, the Journal also features a broad range of ancillary research including, but not restricted to Hematological Oncology, Immunotherapy, AIDS/HIV, Hepatitis C etc. The Journal caters to a diverse readership base comprising of students, medical practitioners, professionals in pharmaceutical companies, advocacy groups, and policy makers. “Hematology and Thromboembolic Diseases” is chaired by an expert editorial board comprised of globally recognized scientists. Every manuscript is subject to vigorous peer-review process, and is approved for publication on the recommendations of distinguished scientists in the field. The published content therefore ensures quality and originality. Apart from research articles, the Journal also publishes high quality Commentaries, Reviews, Case Reports, and Perspectives of pivotal importance. The team at “Hematology and Thromboembolic Diseases” takes immense pride in providing the authors with an efficient and unbiased publishing process. The journal provides rapid turn-around time for manuscript processing; advance posting of accepted articles is another advantageous feature. “Hematology and Thromboembolic Diseases” presents an encouraging platform for authors to contribute their valuable findings towards the field.
Anemia is a therapeutic condition in which the red platelet cells or hemoglobin is not as much as ordinary. Anemia is brought on by either a lessening underway of red platelets or hemoglobin, or an increment in misfortune or devastation of red platelets. Anemia is the most widely recognized issue of the blood cells with it influencing around a quarter of individuals internationally.
Related Journals of Anemia
Iron therapy id the use of oral ferrous iron salts are the most sparing and successful prescription for the treatment of iron inadequacy Anemia. Of the different iron salts accessible, ferrous sulfate is the one most ordinarily utilized. Treatment for iron deficiency concentrates on expanding your iron stores so they achieve ordinary levels and distinguishing and controlling any conditions that brought about the sickliness.
Related Journals of Iron Therapy
Macrophages are important cells of the immune system that are formed in response to an infection or accumulating damaged or dead cells. Macrophages are large, specialized cells that recognize, engulf and destroy target cells. The term macrophage is formed by the combination of the Greek terms "makro" meaning big and "phagein" meaning eat.
Related Journals of Macrophages
Bone marrow is the spongy tissue inside some of your bones, such as your hip and thigh bones. It contains immature cells, called stem cells. The stem cells can develop into the red blood cells that carry oxygen through your body, the white blood cells that fight infections, and the platelets that help with blood clotting.
Related Journals of Bone Marrow Disease
Myeloproliferative neoplasms, or MPNs likewise called myeloproliferative Disorders, or MPDs — are a gathering of issue that are accepted to be brought on by changes in bone marrow undeveloped cells. These foundational microorganisms typically offer ascent to develop cells found in the blood flow, for example, red platelets, which convey oxygen, white platelets, which battle contamination, and platelets, which encourage blood clot.
Related Journals of Myeloproliferative Disorders
Prothrombin time (PT) is a blood test that measures to what extent it takes for the blood oozing to clot. A prothrombin time test can be utilized to check for draining issues. PT is additionally used to check whether drug to avoid blood clusters is working. The prothrombin time (PT) test is requested to help analyze unexplained dying, frequently alongside an incomplete thromboplastin time (PTT) test. The PT test assesses the outward and basic pathways of the coagulation course, while the PTT test assesses the inborn and normal pathways. Utilizing both looks at the incorporated capacity of the greater part of the coagulation elements.
Related Journals of Prothrombin Time
Thromboembolism encompasses two interrelated conditions that are part of the same spectrum, deep venous thrombosis (DVT) and pulmonary embolism (PE). The spectrum of disease ranges from clinically unsuspected to clinically unimportant to massive embolism causing death.
Related Journals of Thromboembolism
Hemostasis is generally considered regarding coagulation pathways or as a surrogate of coagulation. However, hemostasis is much more unpredictable than coagulation, which basically reflects cluster arrangement, as it consolidates a few parts random to the coagulation process.
Related Journals of Laboratory Haemostasis
Polycythemia vera (PV) is a stem cell disorder characterized as a hyperplastic, malignant, and neoplastic marrow disorder. Its most prominent feature is an elevated absolute red blood cell mass because of uncontrolled red blood cell production. This is a rare disorder that occurs more often in men than in women. It is not often seen in people under age 40. The problem is often linked to a gene defect called JAK2V617F. The cause of this gene defect is unknown.
Related Journals of Polycythemia Vera
Bone Marrow Research, Stem Cell Research & Therapy, Current Stem Cell Research and Therapy, Hematology/Oncology and Stem Cell Therapy, International Journal of Hematology-Oncology and Stem Cell Research
Anticoagulants drugs and antiplatelet drugs are a type of medication that is used to eliminate or reduce the risk of blood clots. They are often called “blood thinners”. Instead, these medications help prevent or break up clots in your blood vessels or heart.
Related Journals of Anticoagulants
Acute myelogenous leukemia (AML) is a tumor of the blood and bone marrow the elastic tissue inside bones where platelets are made. Perpetual myelogenous (or myeloid or myelocytic) leukemia (CML), otherwise called constant granulocytic leukemia (CGL), is a disease of the white platelets. It is a type of leukemia portrayed by the expanded and unregulated development of transcendently myeloid cells in the bone marrow and the amassing of these cells in the blood.
Related Journals of Myelogenous Leukemia
The strange shape and poor deformability of the sickled erythrocyte (RBC) have for the most part been considered in charge of the microvascular impediments of sickle cell disease. On the other hand, there is no relationship between the clinical seriousness of this sickness and the vicinity of sickled RBC.
Related Journals of Sickle Erythrocytes
Hematology is the study of blood cells and abnormalities of the cells and proteins (plasma). There is a wide range of hematologic disorders and diseases. In fact, since each disorder is so specialized and unique, it is sometimes the only common link between the different disorders and diseases.
Related Journals of Haematological Disorders In Children
Dendritic cells are a sort of antigen-presenting cell (APC) that shape a vital part in the versatile resistant framework. The fundamental capacity of dendritic cells is to present antigens and the cells are in this way now and again alluded to as "expert" APCs. Dendritic cells are found in tissue that has contact with the outside environment, for example, the over the skin (present as Langerhans cells) and in the linings of the nose, lungs, stomach and digestion tracts.
Related Journals of Dendritic Cells
Journal of Hematology and Thromboembolic Disorders is supporting "3rd International Conference on Hematology & Blood Disorders” during November 02-04, 2015 at Atlanta, USA.
*2017 Journal Impact Factor was established by dividing the number of articles published in 2015 and 2016 with the number of times they are cited in 2017 based on Google Scholar Citation Index database. If 'X' is the total number of articles published in 2015 and 2016, and 'Y' is the number of times these articles were cited in indexed journals during 2017 then, journal impact factor = Y/X